Introduction
The pentameric ligand-gated ion channel (pLGIC) family, in mammals, comprises nicotinic acetylcholine receptors (nAChRs), serotonin type 3 receptors (5-HT 3 Rs), g-aminobutyric acid type A receptors (GABA A Rs), glycine receptors (GlyRs), and zinc-activated ion channels. Their biological function is to bind a specific neurotransmitter, opening an intrinsic channel passively conducting ions across the membrane, which thereby triggers cell depolarization or hyperpolarization. As they are ubiquitously expressed in virtually all neurons, pLGICs contribute to all CNS functions, including sensory and motor processing, central autonomous control, memory and attention, sleep and wakefulness, reward, pain, anxiety, emotions, and cognition. Although their primary function is to mediate neuronal communication, pLGICs, in mammals, are involved in several physiological processes resulting from their expression in various cell types such as epithelial or immune cells (Sanders et al., 2015; Wessler and Kirkpatrick, 2008) .
Numerous mutations that alter the function of pLGICs have been found to cause severe congenital pathologies (Lehmann-Horn and Jurkat-Rott, 2000) including: congenital myasthenic syndrome (a result of mutations in the muscle-type nAChR) (Sine, 2012; Steinlein, 2012) , nocturnal frontal lobe epilepsy (a result of mutations in neuronal nAChRs) (Steinlein, 2012) , several epileptic syndromes (a result of mutations in GABA A Rs) (Macdonald et al., 2010) , hyperekplexia (a result of mutations in GlyRs) (Bode and Lynch, 2014) , and autism (a result of mutations and dysfunctional regulation of several pLGICs) (Dineley et al., 2015; Pilorge et al., 2015; Vien et al., 2015) . In addition, dysfunction of nAChRs and GABA A Rs has been linked to schizophrenia (Braat and Kooy, 2015; Leonard et al., 2002) and neurodegenerative pathologies such as Alzheimer's disease (James and Nordberg, 1995) . pLGICs have thus been extensively studied in an effort to find therapeutic remedies to these pathologies.
pLGICs are protein complexes of 150 to 300 kDa, made up of five identical or homologous symmetrically arranged subunits, filling a cylinder at least 12 nm in height and 7 nm in diameter, and whose rotational axis coincides with the central ion pathway. The binding of an extracellular neurotransmitter stabilizes an open channel conformation through global conformational changes, while prolonged or repetitive application of neurotransmitters promotes a diminution of the response through the stabilization of a closed/desensitized state refractory to activation. In addition, intermediate states in the pathways of activation and desensitization have been identified, indicating that pLGICs can adopt a large repertoire of conformational states, which likely meet physiological needs for the regulation of neuronal activity by neurotransmitters, endogenous regulators, and lipids .
pLGICs

The pLGIC Superfamily from Mammals to Bacteria
Since the first isolation of nAChRs, more than 40 genes coding for vertebrate pLGIC subunits have been identified and grouped into distinct families, according to their neurotransmitter pharmacology (Dent, 2010) : the nAChRs (with 17 known subunits termed a1Àa10, b1Àb4, g, d, and ε), the 5-HT 3 Rs (with 5 known subunits termed A-E), the GABA A Rs (with 19 known subunits termed a1Àa6, b1Àb3, g1Àg3, d, ε, q, p, and r1Àr3), the GlyRs (with 5 known subunits termed a1Àa4 and b), and a single zinc-activated channel subunit (Figure 1) . A minority of subunits can form functional homopentamers; a7-and a9-nAChRs (Couturier et al., 1990; Elgoyhen et al., 1994) ; the 5-HT 3 A receptor (Maricq et al., 1991) ; a1-, a2-, and a3-GlyRs (Grenningloh et al., 1990; Kuhse et al., 1990; Schmieden et al., 1989) ; and r1-, r2-, and r3-GABA A Rs (Cutting et al., 1991; Kusama et al., 1993; Shingai et al., 1996) . Some of these subunits can sometimes assemble with other subunits, as illustrated by a9a10-nAChRs (Elgoyhen et al., 2001) , 5-HT 3 AB receptors (Davies et al., 1999) , and a1b-GlyRs (Langosch et al., 1988) . However, the majority of the subunits, predominantly for neuronal nAChRs and GABA A Rs, assemble together in obligatory heteropentamers. For example, a2, a3, a4, and/or a6 nAChR subunits assemble with b2 and/or b4, and optionally with a5 or b3; similarly, b subunits of GABA A Rs assemble with a and other complementary subunits. In contrast, the muscle nAChR displays fixed subunit stoichiometry and arrangement: a1-g-a1-d-b1 (in adult, with the g subunit replacing the fetal ε subunit [Mishina et al., 1986] ). The combinatorial association of subunits thus generates a large number of receptors with different subunit compositions, stoichiometries, and functional properties. Splice variants of different pLGIC genes also add to the complexity of the pLGIC family (Beeson et al., 1990; Brü ss et al., 1998; McKinley et al., 1995; Zhao et al., 2009) . The rules governing the formation of pentameric complexes are far from being fully elucidated.
pLGICs are widely found in lower organisms, such as the invertebrate Caenorhabditis elegans, Drosophila melanogaster, or Aplysia californica, where they similarly mediate neuronal communication, and also chemotaxis (Dent, 2010) . In addition to the mammalian neurotransmitters described, these invertebrate pLGICs are gated by glutamate, histamine, and protons, adding to the diversity of ligand-gated pharmacology in pLGICs (Dent, 2010) . Some mollusks and annelids also naturally express a truncated version of nAChRs, termed acetylcholine binding proteins (AChBPs), which consist of the extracellular neurotransmitter binding domain of pLGICs in a membranefree soluble form (Huang et al., 2009; Nys et al., 2013) . More recently, numerous pLGICs were found in bacteria and archaea (Tasneem et al., 2005) , including a proton-gated ion channel from the cyanobacteria Gloeobacter violaceus, termed GLIC (Bocquet et al., 2007) , and a GABA/cysteamine-gated channel from Erwinia chrysanthemi, termed ELIC (Zimmermann and Dutzler, 2011) ; however, most of their physiological roles remain elusive. pLGICs in the Nervous System The best-studied member of the mammalian pLGIC family is the muscle nAChR, which aggregates in clusters at the postsynaptic compartment near the site of pre-synaptic neurotransmitter release (Del Castillo and Katz, 1955) . Fast quantal (<1 ms) and high concentration (>1 mM) release of acetylcholine (ACh) triggers the opening of its non-specific cationic channel, letting Na + , K + , and divalent Ca 2+ ions diffuse through the membrane to depolarize the muscle fiber, thereby mediating fast synaptic ''phasic'' transmission (Adams et al., 1980; Katz and Miledi, 1973) . In addition to the neuromuscular junction, cationic nAChRs also mediate post-synaptic transmission in the autonomic ganglia (predominantly a3b4-and a3b4a5-nAChRs [Albuquerque et al., 2009]) , and possibly in the cerebral cortex (a7-nAChRs [Arroyo et al., 2014] ). A high permeability to calcium, notably with a7-nAChR, triggers intracellular metabolic responses in addition to depolarization (Sé gué la et al., 1993) . On the other hand, populations of neuronal nAChRs, notably the predominant a4b2-and a7-nAChRs, are found at the level of the presynaptic, axonal, (A) Phylogeny of human pLGICs with the inclusion of non-human pLGICs (species listed) that have resolved structures, rooted to split anionic with prokaryotic (prok.) channels (bottom) and cationic channels (top). Aligned using ClustalW (Larkin et al., 2007) , with the phylogeny tree generated by PhyML on phylogeny.fr (Dereeper et al., 2008) . Subfamilies are color coded, with mammalian anionic (GABA A Rs, light red; GlyRs, dark red) and cationic (nAChRs, light blue; 5-HT3 A Rs, dark blue; Zinc-activated channels [ZAC] , gray) receptors in solid color, meanwhile invertebrate/prokaryotic (GluCla, purple; GLIC and ELIC, orange; AChBPs, green) dendritic, or somatic compartments of neurons, thus displaying a widespread distribution (Barrantes, 2014) . The other major excitatory cationic receptors, the 5-HT 3 Rs, express predominantly as the A and AB subtype in the brain and modulate the release of many neurotransmitters including dopamine, GABA, glutamate, and ACh (Miquel et al., 2002) .
Prolonged, repetitive, or high-concentration neurotransmitter binding to pLGICs leads to a desensitization process that shuts the ion pathway (Katz and Thesleff, 1957; Papke et al., 2011) ( Figure 1C ). Desensitization may protect the neuronal or muscle fiber synapse from repetitive stimulation or pathologically high tonic concentrations of agonist, by progressively reducing the post-synaptic currents. In addition, desensitized receptors have a higher affinity for the ligand and can reactivate with ligand still bound. Thus, through the removal and subsequent return of receptor subpopulations from and to an open state, desensitization may also shape the time course of post-synaptic currents, slowing response decay and leading to signal prolongation (Jones and Westbrook, 1996) . For extra-synaptic receptors, desensitization may be even more important since prolonged application of low concentrations of agonist that diffuse from the synaptic cleft may promote desensitization without significant activation (Heidmann and Changeux, 1982; Katz and Thesleff, 1957) , whereas exogenous compounds, such as nicotine, in a narrow range of concentrations, promote receptor activation without complete desensitization (Campling et al., 2013) . These properties emphasize the critical role desensitization plays in modulating receptor response.
In opposition to excitatory cationic receptors, anionic GABA A Rs mediate most of the fast inhibitory neurotransmission in the adult nervous system, with the (a1) 2 (b2) 2 g2 receptor as the predominant subunit composition in the brain (Fritschy and Panzanelli, 2014) , while r-containing receptors are expressed predominantly in the retina (Qian and Dowling, 1993) . In comparison, GlyRs predominantly found as a1 and a1b subtypes, mediate inhibitory transmission in more localized areas, notably the brainstem, spinal cord, and substantia nigra (Baer et al., 2009) .
Extra-synaptic pLGICs mediate the ''tonic'' regulation of network activity through their activation by low levels of ambient neurotransmitters (Betz and Laube, 2006; Brickley and Mody, 2012; Yakel, 2013) , thereby modulating the release of other neurotransmitters including GABA, glutamate, and dopamine.
In addition to their respective neurotransmitters, pLGICs are modulated by a wide range of endogenous compounds. In physiological conditions, a4b2-nAChRs are targeted by Lynx, a GPI-anchored neurotoxin-like protein that downregulates their function (Miwa et al., 2011) , and modulated by specific lipids such as cholesterol (Hamouda et al., 2014; daCosta et al., 2013) . GABA A Rs are regulated by endozepines (Christian et al., 2013) and neurosteroids (Hosie et al., 2006) , which are in large part released from glial cells, usually acting as low-concentration potentiators and high-concentration activators. pLGICs are also modulated by ions present in the synaptic cleft, such as zinc for GABA A Rs and GlyRs, and calcium for nAChRs (Galzi et al., 1996a; Laube et al., 2000; Smart et al., 1994) .
pLGICs are also important targets for addictive and therapeutic drugs. A comprehensive picture of all the binding sites have been recently reviewed in several publications (Hamouda et al., 2014; Rucktooa et al., 2009; Sauguet et al., 2015) . This Review does not set out to reproduce in detail the pharmacological relevance of pLGICs, but some notable highlights should be mentioned. nAChRs expressed in the ventral tegmental area have been found to be responsible for nicotine and tobacco addiction (De Biasi and Dani, 2011) , and synthetic positive allosteric modulators (PAMs) targeting neuronal a7-nAChRs were developed as potential neuro-protective agents and cognitive enhancers (Bertrand and Gopalakrishnan, 2007; Gill-Thind et al., 2015) . GABA A Rs mediate part of ethanol's effects (Howard et al., 2011) and are the target of the benzodiazepine class of drugs, which positively modulate their function, thereby producing sedative, anxiolytic, muscle relaxant, and anticonvulsant effects (Fritschy and Panzanelli, 2014) . 5-HT 3 R antagonists, notably the setron class of drugs, are used for the treatment of nausea (Lummis, 2012) . Additionally, pLGICs are also among the major targets for general anesthetics that include a wide range of inhalatory volatile compounds such as desflurane and chloroform, as well as injected compounds such as propofol. At clinical concentrations, they allosterically potentiate GABA A Rs, GlyRs, and 5-HT 3 Rs, while they inhibit nAChRs (Forman et al., 2015; Franks, 2008; Lobo and Harris, 2005) .
3D Structures of pLGICs
General Structure of pLGICs from X-Ray Crystallography The breadth of knowledge on pLGICs was primarily built from the nAChR subfamily, with the muscle nAChR being the first member of the pLGIC family discovered (Langley, 1905) , purified (Changeux et al., 1970) , and observed by electron microscopy (Cartaud et al., 1973; Miyazawa et al., 1999) . The first high-resolution structure of pLGICs came from X-ray crystallography experiments performed on a soluble AChBP (Brejc et al., 2001 ). This structure was used in association with a near-atomic resolution cryo-electron microscopic structure of the Torpedo marmorata nAChR (Miyazawa et al., 1999) to study full-length pLGICs (Unwin, 2005) . Subsequently, X-ray structures of fulllength ancestral-type prokaryotic pLGICs, ELIC (Hilf and Dutzler, 2008) and GLIC (Bocquet et al., 2009; Hilf and Dutzler, 2009 ), were solved. ELIC and GLIC display a fully resolved structure, missing only a few amino acids at the terminals, and have among the shortest amino-acid sequence within the family. These structures show symmetrical homopentamers, with subunits consisting of an 190-200 amino acid extracellular domain (ECD) organized in a b-sandwich fold, including inner and outer b-sheets, followed by a transmembrane domain (TMD) composed of four sequential transmembrane a-helices (M1-M4) connected by short loops (Figure 2A ). The M2 a-helix of each subunit line the channel in the pentameric axis of symmetry and interact with the M1 and M3 a-helices, which in turn interact with the M4 a-helix located at the periphery of the protein, facing the lipids ( Figure 2B ).
Eukaryotic pLGICs structures were subsequently solved, including: the invertebrate glutamate-gated chloride channel (GluCla) from Caenorhabditis elegans (Hibbs and Gouaux, 2011) , the 5-HT 3 AR from Mus musculus (Hassaine et al., 2014) , the human homomeric b3-GABA A R (Miller and Aricescu, 2014) , and more recently the human a3-GlyR (Huang et al., 2015) , as well as the a1-GlyR from Danio rerio (zebrafish) (Du et al., 2015) , the latter being solved by cryo-electron microscopy.
Since GLIC (Bocquet et al., 2007) and ELIC (Zimmermann and Dutzler, 2011) are functional pLGICs, their structures likely represent the minimal common core required for chemo-electric conversion. This common core is highly conserved in all pLGICs whose structures have currently been solved. However, the eukaryotic pLGICs bear extra motifs: (1) an N-terminal a-helix that varies in length between subtypes and lies on the top of the ECD; (2) an intracellular domain (ICD) that greatly varies in sequence and length (80-200 residues) between subtypes and connects the M3 a-helix to the M4 a-helix; (3) post-translational modifications, including N-linked glycosylations, some of which are resolved in the AChBP, 5-HT 3 AR, b3-GABA A R, a1-GlyR, and a3-GlyR structures; and (4) an ultra-conserved disulfide Cysbridge in loop 7 that names the eukaryotic pLGIC Cys-loop receptor subfamily (Figure 2A) . In most structures, the ICD was removed and replaced by a short linker, with the exception of the 5-HT 3 AR. A large portion of the 5-HT 3 AR-ICD was digested by trypsin, and what remained after digestion is partially resolved in the form of two a-helices, one connected to the M3 a-helix and oriented parallel to the plane of the membrane, and one extending from the M4 a-helix toward the cytoplasmic side (Hassaine et al., 2014) (Figure 2A ). This latter M4 a-helix configuration is also seen in the electron microscopy map of the muscle nAChR (Miyazawa et al., 1999) . Modular Functional Architecture of pLGICs The pLGIC structure is thus characterized by abrupt secondary/ tertiary structural changes at the ECD-TMD and TMD-ICD interfaces, highlighting a clear-cut modular architecture.
The ECD carries the binding site for the endogenous neurotransmitter, which is called the orthosteric site according to the IUBCP nomenclature (Christopoulos et al., 2014) . It is topologically conserved in the family and is located at the subunit interface, halfway between the ECD apex and the membrane ( Figure 2B ). Numerous complexes between pLGICs and orthosteric ligands were solved by X-ray crystallography: ELIC with GABA ; GluCla with glutamate (Hibbs and Gouaux, 2011) ; b3-GABA A R with benzamidine (Miller and Aricescu, 2014) ; a1-and a3-GlyR with strychnine (Du et al., 2015; Huang et al., 2015) ; AChBPs with carbamylcholine, nicotine, and a large series of other agonists and antagonists (Billen et al., 2012; Bourne et al., 2010; Rucktooa et al., 2009) ; and AChBP/a7 or /5-HT 3 A chimeras in complex with nicotinic and serotonergic ligands (Huang et al., 2013; Kesters et al., 2013; Nemecz and Taylor, 2011) . These structures show an overall common mode of binding at the orthosteric site.
All neurotransmitters carry a positively charged ammonium group, which is a key pharmacophore, and they bind to the principal subunit of the orthosteric interface . Three loops, termed A, B, and C, contribute to a nest of aromatic residues, stabilizing the ammonium through cation-p interactions (Xiu et al., 2009 ) and/or hydrogen bonding (Hansen et al., 2005) , with loop B playing a principal role and loop C ''capping'' the ligand within the interface (Figure 2C ). The complementary subunit interface is composed of loops D, E, and F; although loops D and E were in fact later found to be b sheets ( Figure 2C ). More variable interactions occur on the complementary side, depending on the ligand and the pLGIC subtype.
The ECD and TMD, covalently linked through the pre-M1 (C-terminal of the ECD) and the M1 a-helix, form an interface through several well-conserved loops: loop 2 (b1-b2 loop) above the top of M2 and the N-terminal portion of the M2-M3 loop; loop 7 (b6-b7 loop, Cys-loop) carrying a canonical FPFD motif, contacts the top of the entire TMD; loop 9 (b8-b9 loop, loop F) above the M2-M3 loop from the adjacent subunit; and the TMD M2-M3 hairpin loop itself, at the subunit interface, which additionally interacts with the pre-M1 region from the adjacent subunit ( Figure 2 ). Mutational studies have previously established the key role of these interface motifs in coupling agonist binding to channel opening (reviewed in Bouzat, 2012; Thompson et al., 2010) .
Interestingly, some isolated ECDs were shown to fold correctly and even self-assemble. Isolated ECDs of GLIC (Nury et al., 2010a) , a1-nAChR (Dellisanti et al., 2007) , and a9-nAChR (Zouridakis et al., 2014) express as soluble monomers and retain a native-like b-sandwich fold in their crystallographic structures. An exception to this observation are the AChBPs, which are naturally truncated from the TMDs and organize as a soluble pentamer, a property probably selected by evolution to allow AChBPs to retain high ACh binding affinity.
Embedded in the plasma membrane, the TMD carries the ion channel that coincides with the pentameric axis of symmetry at the center of the helix bundle (Giraudat et al., 1986) . To access the channel, ions pass through the wide vestibule from the ECD (Hansen et al., 2008 ) ( Figure 2B ). The ion channel is bordered by the M2 a-helices of each subunit, generating a stratified organization in which pentagonal rings of generally homologous residues align along the z axis. For the family of pLGICs, the 20 0 ring generally consists of polar residues (Asp, Asn, Glu, Gln, His, and Lys), with the exception of Ala in GlyRs. Next, two rings of generally hydrophobic residues follow for cationic pLGICs, with the inclusion of Ser/Thr residues for anionic pLGICs at positions 16 0 and 13 0 . Then a highly conserved Leu ring is present at 9 0 , with the exception of GLIC (Ile) and nAChR accessory a5/b3 subunits (Val). This ring is followed by, most commonly, a Thr or Ser ring at 6 0 . Lastly, a variable ring exists at the 2 0 position. Within the M1-M2 loop, cationic receptors usually contain a Glu at À1 0 , with the exception of GLIC where Glu is at À2 0 , whereas anionic receptors contain an Ala at À1 0 and contain an additional residue at À2 0 , usually Pro or Ala ( Figure 3 ). Mutation of this M1-2 loop was found to govern ion permeation, according to charge, thereby supporting its role as a selectivity filter of the channel (Corringer et al., 1999) . The TMD establishes many lipid contacts, primarily with the peripheral M4 a-helix but also with the M1 and M3 a-helices. Interestingly, the TMDs of a4b2-nAChR, a7-nAChR, and a1-GlyR were expressed alone and studied by a combination of electron microscopy, nuclear magnetic resonance, and multi-angle light scattering, revealing bundles of four helices spontaneously interacting together to mainly form pentameric rosettes (Mowrey et al., 2015) . These experiments indicate a major role of the TMD for oligomerization.
Facing the cytoplasm, the ICD plays a major role in aggregating and targeting receptors in muscle and neurons, notably through direct interaction with rapsyn (Zuber and Unwin, 2013) (muscle nAChR) and gephyrin (Fritschy et al., 2008 ) (GABA A Rs and GlyRs). It is also involved in the regulation of pLGIC response by phosphorylation (Han et al., 2013) and allosteric modulation through its interaction with the G bg protein (Yevenes et al., 2003) . To exit the ion channel pore, ions pass through lateral ''windows'' within the ICD (Carland et al., 2013; Kelley et al., 2003; Song and Corry, 2009) . Altering or removing the ICD has dramatic consequences in phenotype (Tsetlin et al., 2011) . Chimeric receptors containing various ICDs also showed an altered assembly, regulation, and functional conductance of pLGICs (Kracun et al., 2008 ). Yet a common practice for enhancing structural resolution has been to remove the ICD, and this does not definitively perturb protein expression.
Genetic engineering showed that the ECD agonist-binding module and the TMD/ICD pore module from different receptors subtypes can be combined with minimal ECD/TMD interface mutations to form functional chimeras, such as the a7-nACh-R(ECD)/5-HT 3 AR(TMD+ICD) (Eiselé et al., 1993) , a7-nACh-R(ECD)/a1-GlyR(TMD+ICD) , ELIC(ECD)/ GLIC(TMD) (Schmandt et al., 2015) , and even bacterial-human GLIC(ECD)/a1-GlyR(TMD) (Duret et al., 2011) and ELIC(ECD)/ a7-nAChR(TMD) . The GLIC(ECD)/a1-GlyR(TMD) and ELIC(ECD)/GLIC(TMD) chimeras were recently solved using X-ray crystallography, showing a high conservation of the common core and of the ECD-TMD interface, even between bacterial and human receptors, that accounts for the compatibility of the two domains to form a functional pLGIC (Moraga-Cid et al., 2015; Schmandt et al., 2015) . It was additionally shown that chimeras of GLIC bearing the ICD from the 5-HT 3 AR, a7-nAChR, a1-GlyR, or r1-GABA A R do not significantly deviate in function from GLIC (Goyal et al., 2011; Mnatsakanyan et al., 2015) .
The Two-State MWC Model for Activation Early electrophysiological experiments on the muscle nAChR showed that acetylcholine application promotes fast activation (<1 ms), i.e., channel opening (Katz and Miledi, 1965) . Two models were proposed to account for the agonist-elicited activation: (1) the induced-fit theory that postulates that substrate binding is a pre-requisite for activation and drives conformational change (Koshland, 1959) ; and (2) the Monod-WymanChangeux (MWC) theory, initially proposed to model the behavior of allosteric enzymes, which postulates that pLGICs spontaneously isomerize between pre-existing states, whereby ligands shift equilibriums toward the states for which they display the highest binding affinity (Monod et al., 1965) . The MWC theory also postulates that the transitions between states preserve the molecular symmetry of the oligomers, implying a concerted reorganization of every subunit. Thus, two symmetrical states, an active high-ligand affinity and a resting low-affinity state, are part of an equilibrium that is incrementally shifted upon each subsequent ligand binding toward the higher-affinity active state, thereby explaining the observable cooperativity of ligand binding and ligand-elicited activation.
Since the development of patch-clamp electrophysiology, single channel recordings have provided unprecedented kinetic information about gating. Single channel recordings showed that at low agonist concentrations, groups of openings are divided into bursts, separated by channel closing due to agonist dissociation (Colquhoun and Sakmann, 1998) , whereas at high agonist concentrations, these bursts are delimited by desensitized intervals (Auerbach, 2012; Katz and Thesleff, 1957) . Extensive work on the muscle nAChR demonstrates a good fit of the MWC theory to two states of the receptor's behavior, resting (R) and active (A) (Auerbach, 2012) . This R/A model quantitatively describes the activation of the un-, mono-, and di-liganded forms. The spontaneously open unliganded isomerization constant, in the absence of ACh, was measured for gain-of-function mutants, allowing extrapolation to the wild-type, which opens for an average of $80 ms at a frequency of about once every 15 min (Purohit and Auerbach, 2009 ).
Resting-like and Active-like Conformations Observed by X-Ray Crystallography Resting-like Conformations The MWC model thus postulates the existence of an R state carrying a closed channel and low agonist affinity, and an A state with an open channel and a higher agonist affinity. As stated above, several atomic structures of pLGICs have been solved by X-ray crystallography and electron cryo-microscopy. In these experiments, the proteins are extracted from the lipid bilayer, solubilized and purified in detergent, and in the case of crystallography, engage in multiple protein-protein interactions in the asymmetrical crystallographic unit. Despite these non-physiologically relevant conditions, a common depiction of the activation mechanism is emerging from these structures and previous molecular dynamics simulations (Calimet et al., 2013; Cecchini and Changeux, 2015; Sauguet et al., 2014) .
GLIC has been resolved at an activating proton concentration (pH4), and one that elicits no activation (pH7) (Bocquet et al., 2009; Hilf and Dutzler, 2009; Sauguet et al., 2014) . The binding site(s) for proton activation has/have yet to be identified, but it/ they is/are predominantly thought to reside within the ECD (Duret et al., 2011; Gonzalez-Gutierrez et al., 2013; Prevost et al., 2013a) , although the TMD has also been suggested to play a role (Wang et al., 2012; Rienzo et al., 2014) . In parallel, the GluCla construct, not actually activated by glutamate but by ivermectin binding to its TMD, was solved in the presence and absence of ivermectin (Althoff et al., 2014; Hibbs and Gouaux, 2011) . Finally, the a1-and a3-GlyRs were solved in complexes with the competitive antagonist strychnine, and the a1-GlyR in the presence of glycine (Du et al., 2015; Huang et al., 2015) .
The GLIC-pH7 and GluCla-apo structures display a closed channel and represent the pharmacological un-liganded resting state, whereas the a1-and a3-GlyRs with strychnine bound represent an antagonist-bound resting state. In all structures, pore side chains point towards the central axis to form at least one hydrophobic constriction. GLIC has a constriction at the level of Ile9 0 (1.7 Å radius) and Ile16 0 (2 Å radius), whereas GluCla constricts at Leu9 0 (1.5 Å radius). The a1-/a3-GlyR structures show the constriction point at Leu9 0 (1.4 Å radius) with the addition of Thr13 0 and Ser/Ala20' ($2-3 Å radius) (Figure 3 ). These Channel states represented by two M2 a-helices (prime numbering of residues) from opposite facing subunits with pore radii, calculated using Hole (Smart et al., 1993) , shown to the right. The radii of H 2 O, K + , and hydrated-K + are shown as dashed lines. Top: Closed/Resting states from GLIC, GluCla, ELIC, a1-GlyR, and 5-HT 3 AR; middle: Open/Active states from GLIC, GluCla, and a1-GlyR; bottom: Expanded/Desensitized states from b3-GABA A R, a1-GlyR, and GluCla. Receptor subunits are color coded with pore radii traces.
A sequence alignment of the M2 a-helices is found underneath.
geometries clearly point to non-conductive conformations, since the unfavorable interactions between these hydrophobic ''nanopores'' and water lead to a stochastic liquid-vapor transition, ''dewetting'' the pore, and generating an impassable energy barrier to ion conduction (Aryal et al., 2015) . The structure of ELIC (Hilf and Dutzler, 2008 ) also shows a closed channel with a hydrophobic constriction at the 9 0 and 16 0 positions (Figure 3 ), but this conformation is observed both in the presence of a bound antagonist (ACh [Pan et al., 2012]) or agonist (GABA ). An ELIC(ECD)/ GLIC(TMD) chimera also shows a closed channel with a TMD nearly identical to GLIC-pH7, whereas the ECD has a synonymous conformation to the other ELIC structures previously determined (Schmandt et al., 2015) .
The 5-HT 3 AR structure equally shows a unique arrangement of the TMD with a particular rotamer of Ile9 0 side-chain in the channel, yet this only generates a local constriction of a 2.5 Å radius (Figure 3 ) (Hassaine et al., 2014) . Assignment of these conformations to a physiological state has remained elusive thus far. Active-like Conformations GLIC-pH4, GluCla-ivermectin(/glutamate /picrotoxin /iodide), and a1-GlyR-glycine(/ivermectin) structures show a large opening of the constrictions seen in the closed-channel structures. The constriction of the pore (2-2.5 Å radius) in all cases shifts to the intracellular side, between the À2 0 and 2 0 positions (Figure 3 ). This pore geometry is consistent with a wealth of biochemical data collected on the open state, from measurements of cysteine accessibility, lysine scanning mutagenesis, and other mutagenesis studies which support the conclusion that the channel constriction between À2 0 and 2 0 constitutes the selectivity filter of the pore, screening permeant ions according to their charge (Corringer et al., 1999; Cymes et al., 2005; Galzi et al., 1992; Keramidas et al., 2004; Wilson and Karlin, 1998) .
A high-resolution (2.4 Å ) GLIC-pH4 structure allowed the identification of two ordered water pentagons within the pore, near the 2 0 and 6 0 positions, with one sodium ion between them. These data were used as a template to perform molecular dynamics simulations where a cation was pulled through the pore (Sauguet et al., 2013b) . In the hydrophobic upper half of the pore, the sodium ions remain highly hydrated by two layers of water molecules, which cover the surface of the pore and interact with the carbonyl oxygens of the main chain. Once the ions pass to the lower half of the pore, the distribution of water molecules becomes strongly anisotropic, with transient interactions between the permeant ion and the side-chain hydroxyl/ carboxylate moieties of Ser6 0 , Thr2 0 , and Glu-2 0 residues. Glu-2 0 alternates between an upward and a downward conformation, thereby escorting the diffusing ion at the pore exit. A similar mechanism has been proposed for the muscle nAChR, which bears a ring of glutamates at the À1 0 position; therefore, one can assume cationic ion permeation functions in this manner Cymes and Grosman, 2012) . Electrostatic calculations on both GLIC-pH4 and GluCla-ivermectin indicate that the upper half of both channels may conduct cations and anions equally well, although this was shown to depend on the side-chain orientation of Ser/Thr6 0 (Sauguet et al., 2013b) . In contrast, the lower part of the channel is strongly electronegative for GLIC and electropositive for GluCla, contributing to their opposite charge selectivity. Calculations on the 5-HT 3 AR corroborate the idea that ions experience the same hydrophobic environment in the upper half of the pore, whereas the potential force increases significantly for anions in the lower half of the pore (Di Maio et al., 2015) . The overall data point to the existence of a hydrophobic ''activation gate'' near the 9 0 position, although the conductance of certain ''active-like'' structures, such as that of the a1-GlyR-glycine/ivermectin, has been debated (Du et al., 2015) .
It is noteworthy that, with regard to the TMD, the conformation of ivermectin-bound GluCla and a1-GlyR, along with GLIC-pH4 are highly similar. However, the a1-GlyR-glycine shows a local expansion of the cytoplasmic side of the pore as compared with a1-GlyR-glycine/ivermectin-bound form (from a radius of 3 to 4.4 Å ) (Figure 3 ). This conformation was proposed to represent the fully open conformation of the GlyR (Du et al., 2015) , raising the idea that the ivermectin-bound structures might actually represent a closed, possibly desensitized conformation. However, the a1-GlyR is known to fluctuate between different sub-conducting states from single-channel experiments , and the observed radius of the a1-GlyRglycine pore is larger than that evaluated from a pattern of permeation with ions of increasing size (2.65 Å ) . Future work is needed to investigate the conformational fluctuation at the cytoplasmic border of the TMD, notably in the presence of the intracellular domain that might apply additional structural constraints.
Activation Transition Deduced from X-Ray Structures
The GLIC Transition Superimposing the GLIC-pH7 and GLIC-pH4 structures reveals the global reorganizations associated with the activation gate opening that is stabilized by protons (Figure 4) . At the ECD, GLIC-pH7 is characterized by an extended conformation where the subunits are loosely packed, with relatively few interactions, generating large solvent-accessible surfaces at the ECD-ECD interfaces as well as quaternary flexibility. Transition from the pH7 to the pH4 form can be approximated by a rigid-body movement of each subunit's b-sandwich, leading to a more compact arrangement with a 180 Å 2 increase in surface-contact at the subunit interfaces (Sauguet et al., 2014) . The b-sandwiches move radially toward the central pentameric axis of symmetry, resembling the ''un-blooming'' of a flower, and also tangentially in a global anti-clockwise twist of the whole ECD (Figures 4 and 5C ). Loop C shows an overall tertiary motion, where the body of the loop rotates to close up on the orthosteric pocket, while the tip of the loop follows the quaternary shift of the complementary subunit ( Figure 5C ). Interestingly, both the twisting and un-blooming motions were predicted using normal mode analysis on other pLGICs (Bertaccini et al., 2008; Taly et al., 2005) . In the TMD, the M3 and M4 a-helices are almost immobile (when performing a local TMD alignment of the pentamers), while the upper parts of the M2 and M1 a-helices undergo a tilting motion of respectively 17 and 10 . Both a-helices bend near the middle of the TMD, at 9 0 for the M2 a-helix and Pro204 for the M1 a-helix. In the process, the M2 a-helix approaches the M3 a-helix from the same subunit and the M1 a-helix from the adjacent subunit (Figure 4) . Consequently, the bundle of M2 a-helices undergoes a concerted anticlockwise twist, according to an iris-like motion, while both Ile9 0 and Ile16 0 side chains move away from the pore and toward the helix interface to open the gate. Interestingly, mutations of the hydrophobic residues into more polar residues, in all pLGICs, produce marked gain-offunction phenotypes stabilizing the active state as compared to the resting state, confirming their involvement in channel gating (Chang and Weiss, 1999; Labarca et al., 1995; Revah et al., 1991; Yakel et al., 1993) . In addition, a systematic survey of mutations performed on the muscle nAChR, analyzed by single channel recordings (Purohit et al., 2013) , are also in agreement with the hypothesis that activation requires the opening of the activation-gate hydrophobic block.
At the ECD-TMD interface of GLIC, among the more subtle motions of the ECD-interacting loops, the M2-M3 loop undergoes a pronounced lateral revolving motion around the M3 a-helix, which produces a 4 Å shift of the loop away from the pentameric axis (Figure 4) . This movement generates a redistribution of many side-chain interactions with neighboring motifs, such as the well-conserved Leu22 0 , which moves from a downward binding mode, where it interacts with the TMD, to an upward binding mode, where it interacts with residues of loop 7 (Phe116 and Tyr119). In addition, the canonical Pro23 0 passes 
pLGIC Transitions
Red, resting-like state conformation; green, active-like state conformation. In each panel, the top-down view of the ECD (top) and TMD (bottom) are shown, along with a three subunit side view of the full receptor (middle). All structures were aligned using the whole pentamer. Left: GLIC transitions (pH7-> pH4); middle: GluCla transitions (apo->ivermectin-bound); right: a1-GlyR transitions (strychnine->glycine/ivermectin-bound). Arrows indicate gate-opening transition motions, with curved arrows representing twisting motions and broad arrows translations/tilts. beneath Lys33, which lies at the tip of loop 2, and plausibly contributes to the stabilization of the loop in the open form conformation. From the structure-inferred transitions, it appears clear that the M2-M3 loop is a key element in allosterically coupling the orthosteric ligand pocket of the ECD and the activation gate of the TMD.
The GluCla Transition
The transition inferred from the two GluCla structures shows important similarities with that of GLIC (Figure 4) . At the ECD, the subunit b-sandwiches display essentially the same un-blooming and twisting motions, although with smaller amplitudes at the apical extremity. As with GLIC, this leads to a narrowing of the subunit interface that holds the orthosteric site for glutamate. Loops A, B, and C move in quasi rigid-body motion to come closer to the complementary subunit, and the global ECD un-blooming motion produces a shift of the complementary subunit inner b-sheet towards the central axis of symmetry ( Figures 4 and 5B). During this transition, Arg123 rotates from an upward to a downward conformation, emptying the orthosteric pocket and allowing the binding of glutamate ( Figure 5B ). In the GluCla active-like structure, bound glutamate elicits cationp interactions with Tyr151 (loop B) and is in close proximity to Phe91 (loop A) and Tyr200 (loop C) from the principal subunit, while hydrogen bonding with Arg37, Arg56, and Ser121 from the complementary subunit ( Figure 5A ). This binding is rein- forced through Arg37 hydrogen bonding with Lys171, on loop F, which rotates from a downward to an upward conformation in the active-like structure ( Figure 5B) . Altogether, the compact organization of the binding site in the active state is consistent with an increase binding affinity, which is a key feature of the MWC model.
At the TMD level, the GluCla transition is associated with a global reorganization of the TMD, rotating anti-clockwise by 10 around each subunit's M1 a-helix, which contrasts with the local motion of the M1 and M2 a-helices seen in the GLIC activation model (Figure 4 ). In the process, the M2-M3 loop moves 4-5 Å out of the pore in a horizontal motion, with Pro23 0 passing beneath loop 2 as seen in GLIC (Althoff et al., 2014; Calimet et al., 2013) . In contrast to the iris-like motion seen in GLIC, the M2 a-helices tilt in a radial direction, and the TMD twisting leads to the opening of a gap between the M3 a-helix and the M1 a-helix of the adjacent subunit to accommodate ivermectin binding ( Figure 6A ). The a1-GlyR Transition According to the MWC theory, all states are in equilibrium with each other. Although the a1-GlyR was not solved in an apostate, it is pertinent to describe the transition between the strychnine-bound and glycine/ivermectin-bound form, even if the probability of such a transition at the physiological level remains unclear. In the basal portion of the ECD, the GlyRstrychnine bound structures are nearly synonymous with that of GluCla-apo, and therefore the transition is similar to that of GluCla (Figure 4) . In contrast, the GlyR-strychnine-bound structures are already ''un-bloomed'' in the apical portion of the ECD, resembling the a1-GlyR-glycine-bound conformation. Additionally, loop C undergoes a major tertiary movement, not seen in the GluCla transition ( Figures 5B and 5D) . Therefore, the overall activation transition can no longer be described as an ''un-blooming'' motion of the ECD, rather the apical half maintains only a subtle ''un-blooming'' action, whereas the ECD-TMD interface resembles that of a diaphragm shutter opening.
At the level of the TMD, the GlyR-strychnine and GluCla-apo conformations are commensurate at the level of the backbone a-carbon chain, as are the a1-GlyR-ivermectin-bound and GluCla-ivermectin-bound structures ( Figure 6A ). However, the two strychnine-bound structures differ at the level of the M1-M2 linker. The a3-GlyR X-ray crystal structure has a radial twist in comparison to the a1-GlyR-strychnine, which aligns well with the GluCla-apo structure in this region. The movement of the TMD is therefore similar to the tilt transition and rotation of the a-helix bundle around the M1 a-helix of GluCla (Figure 4) . Interestingly, the idea that an antagonist-bound conformation differs from an apo-conformation only in the ECD is suggested by voltage-clamp fluorometry experiments showing that strychnine produces conformational motions of the ECD without opening the pore (Pless and Lynch, 2009) . Orthosteric Site Transition Previous work on AChBPs described a closed (capped) versus open (uncapped) conformation of loop C for agonists' versus most antagonists' binding, respectively, with the suggestion that the capping movement might contribute to activation Wang et al., 2009) . AChBPs display weak quaternary flexibility in comparison to pLGICs (Nemecz and Taylor, 2011) ; therefore, only tertiary movements were observed. The a1-GlyR (antagonist-agonist) loop C movement is analogous to that seen in AChBPs, whereas the GLIC (apo-open) movement is markedly different, and GluCla shows no tertiary change. These differences could be a result of the fact that, in GLIC, proton interaction does not overlap with loop C (Gonzalez- Gutierrez et al., 2013; Prevost et al., 2013a) , and the possible influence from the Fab fragment used for crystallization in GluCla. Although, a tertiary ''capping'' movement of loop C might contribute, for instance, to the priming of particular interfaces before the global reorganization, it is most likely that quaternary reorganizations, seen in all cases, are key in the agonist-stabilized activation mechanism.
In light of the orthosteric site rearrangements seen in X-ray structures, one can speculate about the sequence of events occurring during agonist-elicited activation. The GluCla-ivermectin active-like structures show a near-identical conformation at the orthosteric site regardless of the binding of glutamate. Consistent with a conformational selection mechanism in physiological conditions, the receptor would spontaneously isomerize toward the active-like conformation, followed by high-affinity binding to glutamate, providing energetic stabilization and displacing the allosteric equilibrium toward the active state. The resting state of pLGICs is also expected to bind to orthosteric agonists, although with lower affinity than the active state; thus, at high agonist concentrations that are typical of synaptic transmission, neurotransmitter binding probably occurs to the resting state of the pLGIC, which then quickly transitions to the active conformation (Sine, 2012) .
Interestingly, structures of the a1-and a9-nAChR subunit's ECDs show that ligands can bind to monomeric subunits carrying the principal component of binding (Dellisanti et al., 2007; Zouridakis et al., 2014) . One could therefore speculate that, in the resting state, low-affinity binding is primarily mediated by the principal component, and agonist binding favors the unblooming motion that increases affinity for subsequent agonists, as seen by the property of ligand-binding cooperativity in pLGICs, thereby further stabilizing an ECD conformation that triggers activation.
Comparison of the GLIC, GluCla, and a1-GlyR Mechanisms Altogether, a common gating mechanism is observed for GLIC, GluCla, and a1-GlyR, where the M2-M3 loop acts as a key coupling-element. It interacts with the bottom of the ECD interface and undergoes a large outward translation that is concerted with gate opening (Figure 4) . Agonist binding stabilizes a quaternary twisting/un-blooming reorganization of the ECD triggering channel activation; meanwhile, small antagonists possibly partially block the ''un-blooming'' motion and thereby lock a distinct non-conducting state. Yet, significant structural differences are observed between subtypes, notably at the TMD. The GLIC-pH7 and GluCla-apo structures show different conformations, either due to species differences or to the occurrence of several resting conformations. We have attempted to classify these structures according to the early three-state (resting-active-desensitized) MWC model (Figure 7 ), yet this classification suggests that multiple related sub-states are necessary in order to properly depict each state. This was anticipated from single channel experiments and from earlier theoretical work (Galzi et al., 1996b) . Transition Pathway of Deactivation Explored by Molecular Dynamic Simulation Molecular dynamics simulations in a fully solvated explicit-membrane environment were performed to model the de-activation pathways starting from the open forms of GLIC and GluCla. In a first study, the GLIC-pH4 structure was set up instantaneously at pH7 and submitted to a 1 ms simulation (Nury et al., 2010b) . The simulation shows an asymmetric channel closure that rapidly takes place at the level of the activation gate followed by a progressively increasing quaternary twist. In the GluCla, a similar procedure was used by instantaneously removing bound ivermectin. This time, the analysis shows a rapid global structural change to a partially twisted conformation, followed by a loss of hydrogen-bonding contacts of glutamate and by the movement of the M2-M3 loop toward the central axis (Calimet et al., 2013) . These different mechanisms thus reveal the complexity of unraveling the molecular events underlying the transition of pLGICs. Future molecular dynamics simulations starting from the recently solved resting conformations will undoubtedly give new insights into this complexity.
Other States in the Conformational Pathway
States in the Activation Pathway Inferred from Kinetic Models Activation of pLGICs involves a cascade of structural events that occur in the ms to ms timescale (Chakrapani and Auerbach, 2005) . The transition state of the activation pathway was studied using rate-equilibrium free-energy relationships (REFERs) on the muscle nAChR. A mapping of the energetic destabilization of the transition state versus native state that results from introduced mutations suggests that both the orthosteric binding site and the M2-M3 loop (specifically residues Ile18 0 , Pro23 0 , and Ser26 0 ) move first during the transition, followed by the rest of the ECD, and then the TMD (Purohit et al., 2013) . Measurements for a nAChR engineered to gate constitutively also suggest that the conformational pathway of activation is fundamentally the same with and without agonist (Purohit and Auerbach, 2009) , agreeing with MWC. However, some theoretical questions have been raised concerning these analyses (Edelstein and Changeux, 2010) .
Investigations of short-lived electrophysiological events also revealed the presence of intermediate states during activation, Highly simplified structures are represented as two subunit compositions with the ECD as a large rectangle and the TMD as a small rectangle and a cylinder for the M2 a-helix, with color coding representing similar conformations. Resting-like apo conformations show two distinct forms (GluCla-apo and GLIC-pH7), meanwhile antagonistbound conformations and the locally closed conformation of GLIC would also be considered resting states. The active-like conformations of GLIC-pH4, as well as ivermectin-bound GluCla and a1-GlyR, could be grouped into one synonymous active state, whereas the expanded glycinebound a1-GlyR conformation would define another. Finally, only one structure has been unequivocally deemed to be in a desensitized-like conformation, which is that of the b3-GABA A R. Assignment of the ELIC, 5-HT 3 A, and POPCbound GluCla structures remains elusive and therefore these are not represented.
implying an early transition of the receptor toward a higher-affinity conformation of the orthosteric site, followed by a late transition involving channel opening. For both the muscle nAChR and the a1-GlyR, a ''flip'' F state was proposed to intervene during gating, where a ''flipped'' symmetrical conformation is stabilized by agonist binding (Lape et al., 2008; Sivilotti, 2010) . Entry into the flip state is then followed by channel opening, independent of the intrinsic efficacy of agonists (Lape et al., 2008) . In parallel, kinetics modeling of the muscle nAChR showed that incorporation of a brief extra state improves the statistical fit of the data and thereby suggests the occurrence of multiple functionally pre-activated or ''primed'' states together with multiple open sub-states (Mukhtasimova et al., 2009; Sine, 2012) . Studies on other pLGICs have even required a refined flip/priming model in order to account for the functional data (Krashia et al., 2011; Marabelli et al., 2015) . Interestingly, the prime model, developed on the heteromeric muscle nAChR, has been suggested to involve asymmetric transitions, thereby departing from one of the MWC's initial postulates.
Asymmetry is also supported through the importance of the principal subunit in the functional effect of agonist-elicited activation. Examining the maximum change in isomerization constant between conducting and non-conducting states, following mutations in the muscle nAChR and GlyR, shows a marked effect in the a subunit as compared to the b and other complementary/ accessory subunits (Purohit et al., 2013; Shan et al., 2003) . Altogether, these observations therefore require an extension of the MWC model. The Locally Closed Conformation Among pLGICs, GLIC has been the most extensively characterized by X-ray crystallography, revealing conformational features that might be relevant to the conformational pathway of activation. Interestingly, in the GLIC-pH7 crystal structure, a large structural variability is observed between the ECDs of the four pentamers seen in the asymmetric unit, highlighting large intrinsic quaternary/tertiary fluctuations in this state. These fluctuations are thought to prefigure the transition toward the active GLIC-pH4 state, suggesting that they might be related to the early events of activation, such as the flipped or primed states. Among the 20 subunit interfaces of these four pentamers, the loop C of the orthosteric site shows a high variability in conformation, from an extended to a contracted conformation, with a 4.3 Å range in the distance from loop B (Arg133-Ca) to loop C (Asp 178-Ca). Specific interfaces thus appear to have a preclosed conformation of loop C, a feature proposed through cross-linking experiments to favor primed states and activation (Mukhtasimova et al., 2009) .
In parallel, a crystal structure of a GLIC variant carrying a C-terminal poly-histidine tag shows two conformations coexisting at pH4. In addition to the open form, GLIC adopts a ''locally closed'' conformation that is similar to the open form, with a near identical conformation of the ECD, but where the upper part of the M2 a-helix and the M2-M3 loop are in a closed conformation similar to the GLIC-pH7 form Sauguet et al., 2014) . Without the poly-histidine tag, the protein adopts uniquely the open form, but a series of independent mutations altering/disrupting the set of interactions occurring at the ECD/TMD interface promotes multiple locally closed forms with different local conformations of the M2-M3 loop. These include covalent bridging (M2-M3 loop to loop 2) or point mutations (Glu19 0 Pro, Thr25 0 Ala, and Tyr27 0 Ala) (Gonzalez-Gutierrez et al., 2013; Prevost et al., 2012) . Thus, the locally closed conformation might resemble an intermediate in the activation pathway, whereby the ECD is in the activated form while the TMD is still in the resting form, as inferred from the previously discussed nAChR electrophysiological experiments.
Interestingly, the GLIC(ECD)/a1-GlyR(TMD) chimera was also solved in the locally closed form (Moraga-Cid et al., 2015) . In addition, stabilizing this locally closed conformation for the a1-GlyR, through disulfide bridging, shows a gain-of-function phenotype associated with a decrease in the maximal currents, supporting the contribution of this state to the physiological response, possibly as an intermediate during activation and/or desensitization (Prevost et al., 2013b) .
Desensitization of pLGICs A Minimum Two-State Kinetic Mechanism for Desensitization
In the early 1980s, electrophysiological and stopped-flow experiments on the muscle-type nAChR (from Rana pipiens and Torpedo marmorata, respectively) demonstrated that desensitization is at least biphasic with a 10-100 ms fast-desensitization followed by a 1-60 s slow-desensitization process (Heidmann and Changeux, 1980; Sakmann et al., 1980) . Time-resolved affinity labeling shows that the fast-and slow-desensitized states are structurally distinct (Yamodo et al., 2010) and electrophysiological recordings suggest that the multi-exponential desensitization processes apply to other pLGICs (Keramidas and Lynch, 2013) . Overall, those data were represented by a minimal fourstate MWC allosteric model, in which the R and A states isomerize with a fast desensitized ''intermediate'' I state and a longest-lived desensitized D state (Edelstein et al., 1996; Heidmann and Changeux, 1978; Neubig and Cohen, 1980) ( Figure 1B ). In addition, single-channel analysis of desensitization suggests a more complex landscape of more than five short-lived and long-lived conformations that could be distinguished by their kinetic properties (Elenes and Auerbach, 2002) .
A Plausible Mechanism for Desensitization
Although not gated by GABA, the homomeric b3-GABA A R structure was crystallized with a bound synthetic agonist, benzamidine (Miller and Aricescu, 2014) . The geometry of the M2 a-helices is unlike any other conformation, still generating a funnelshaped pore, but with a bent curvature in the middle and an anti-clockwise rotation of about 20 of the whole TMD, rotating Leu9 0 side chains out of the pore leading to a 3 Å increase in its radius in comparison to the open GluCla (Figure 3) . However, the selectivity filter at the level of Ala-2 0 forms a narrow hydrophobic constriction of 1.5 Å , thereby preventing ion translocation (Figure 3 ). This unique conformation was suggested to correspond to a desensitized state, where the activation gate is open but where a putative desensitization gate would be closed.
Among the protein regions modulating desensitization (reviewed in Keramidas and Lynch, 2013) , the selectivity filter was shown to be a major locus for mutations altering desensitization in anionic pLGICs. For example, the Pro-2 0 Thr mutation, which is responsible for hyperekplexia, causes a major acceleration of desensitization of the a1-GlyR (Saul et al., 1999) , and mutations at the bottom of the M2 and M3 a-helices, just behind the selectivity filter, strongly affect desensitization, with minimal effects on activation, in both GlyRs and GABA A Rs (Gielen et al., 2015) . In addition, the channel blocker picrotoxin, known to bind between the rings of Thr2 0 and Pro-2 0 in the GluCla (Hibbs and Gouaux, 2011) , was shown to inhibit desensitization of anionic pLGICs in the presence of agonist (Gielen et al., 2015) , altogether supporting the idea that reorganization of this region is crucial during desensitization. Interestingly, site-directed spin labeling and electron paramagnetic resonance spectroscopy of GLIC reconstituted in lipidic vesicles suggest that the desensitization gate is located in the pore under the activation gate (Velisetty et al., 2012) . The occurrence of separate gates for activation and desensitization was previously hypothesized based on kinetic models (Auerbach and Akk, 1998) and revealed based on timeresolved affinity labeling experiments (Yamodo et al., 2010) . Interestingly, voltage-clamp fluorometry experiments on the a1-GlyR point to a major role of the ECD-TMD interface, since desensitization-specific conformational changes are occurring in the vicinity of Ala52 at the tip of loop 2, Gln219 in the pre-M1-region, and Met227 at the top of the M1 a-helix (Wang and Lynch, 2011) . In contrast, a majority of positions labeled in the ECD that undergo rearrangements during activation do not appear to move during desensitization, notably residues composing the orthosteric site for glycine (Pless and Lynch, 2009; Wang and Lynch, 2011) . Similar observations were made on GABA A Rs showing that the ECD contracts during activation and remains in a similar conformation throughout desensitization (Akk et al., 2011) . These observations would support the hypothesis that transitioning from the active state to the desensitized state is predominantly achieved by motions in the TMD, reorganizing the ECD-TMD interface and closing the intracellular desensitization gate.
The functional data on the desensitization gate show an effect on the slow-desensitizing state (Gielen et al., 2015) . It has been suggested that the fast-desensitizing state could arise from an asymmetric movement of residues on a single subunit that blocks the pore at this level, yielding a closed channel (Yamodo et al., 2010) . Therefore the b3-GABA A R structure could represent the symmetrically more stable slow-desensitized state, whereas the multiple desensitization profiles seen in population measurements could be changes in the population equilibriums of asymmetric intermediate desensitized conformations (Prince and Sine, 1999) . Further experimentation is needed to elucidate this complexity.
Mechanisms of Modulation by Allosteric Effectors
The pLGIC function is modulated by a variety of natural and synthetic molecules that act at several levels within their structure. Binding sites that are non-overlapping with the orthosteric site are called allosteric according to the IUPAC nomenclature (Christopoulos et al., 2014) . Allosteric sites were identified to play a major role in pLGIC regulation by endogenous and exogenous molecules, and the identification of their binding sites started with channel blockers (Giraudat et al., 1986 ) and modulating ions, such as calcium, which potentiates the a7-nAChR (Galzi et al., 1996a) , or zinc, which inhibits GABA A Rs and potentiates GlyRs (Laube et al., 2000; Wooltorton et al., 1997) . Affinity labeling, mutational studies, and X-ray crystallography revealed multiple allosteric binding sites that are scattered throughout the protein, notably at the subunit interface (Hamouda et al., 2014; Sauguet et al., 2014; Spurny et al., 2015) (Figure 2B) .
From the gating reorganizations proposed before, we may now investigate these sites not simply in a pharmacological perspective, but also in view of the mechanisms used to promote activation or desensitization. As previously stated, we do not mean to provide a comprehensive picture of all the binding sites that have been recently reviewed, but rather to focus on the particular sites for which conformational changes have been addressed by structural studies.
Pseudo-orthosteric Binding Sites
At the ECD, we already described that the contraction of the subunit interface that is concomitant with activation reshapes the orthosteric binding pocket, thereby increasing the affinity for neurotransmitters and agonists. A particular class of positive and negative allosteric modulators (PAMs and NAMs) is known to bind to pseudo-orthosteric sites, which are at the same position as the orthosteric site but at different subunit interfaces. Benzodiazepines are probably the best-described PAMs binding at such sites and act by increasing the apparent affinity for GABA. They bind to the a/g interface of GABA A Rs, while GABA binds at the b/a interface (Boileau et al., 1999) . These allosteric compounds have been structurally visualized in the orthosteric-like pocket through mutated forms of AChBPs, binding cocaine and other PAMs, as well as benzodiazepine bound to the ELIC structure Spurny et al., 2012) . The structure of ELIC in complex with flurazepam shows a binding into such an ''inter-subunit'' cavity, and it is plausible that their stabilization of a compact interface site contributes to their modulatory action . Allosteric Binding Sites for General Anesthetics and Alcohols As previously mentioned, most pLGICs are modulated, either positively or negatively, by general anesthetics. Structural and functional studies have shown that general anesthetics, which are small amphipatic compounds, bind at multiple locations on pLGICs including: the ECD , the ECD/TMD interface (Yip et al., 2013) , and in the central channel (Fourati et al., 2015; Spurny et al., 2013) . It is believed that their predominant mode of action resides in the upper part of the TMD within the intra-subunit bundle of a-helices (Nury et al., 2011) .
GLIC, which is inhibited by general anesthetics at clinical concentrations (Weng et al., 2009) , has been used as a model to investigate their mechanism of action. Co-crystallizations of GLIC in the active state, at pH4, with desflurane and propofol showed that they bind to a common ''intra-subunit'' cavity in the upper part of the TMD, lined by residues from the M1, M2, and M3 a-helices (Nury et al., 2011) . Affinity labeling experiments show that a photo-activatable propofol derivative binds similarly to the muscle nAChR, and pharmacological assays suggest that it labels a desensitized conformation Jayakar et al., 2013) .
Subsequently, mutational screening of GLIC identified a single mutant, Phe14 0 Ala, that is potentiated by general anesthetics and ethanol (Howard et al., 2011) . The GLIC-Phe14 0 Ala mutant exhibits the same active-state crystal conformation as wild-type GLIC (Sauguet et al., 2013a) but removal of the phenylmoiety creates a new cavity at the subunit interface ( Figure 6C ). Structural inspection of the resting state of GLIC shows that the cavity is profoundly reorganized as a consequence of the tilt of the upper part of the M2 a-helix. A cavity, accessible from the vestibule in the resting conformation, is reduced in size upon activation with the overall TMD motions bringing Glu19 0 and Asn15 0 into proximity with ethanol enabling hydrogen bonding interactions ( Figure 6C ). Ethanol and bromoform, which both potentiate the receptor, bind in this cavity and stabilize the open conformation, as indicated by an important decrease in crystal structure B-factors. Mutations of Ile16 0 Phe and Asn15 0 Ala with Phe14 0 Ala show an impaired potentiation and are consistent with a scheme where ethanol and other general anesthetics bind to a preformed cavity in the upper hydrophobic compartment of the TMD, providing energetic stabilization of the active state (Sauguet et al., 2013a) .
Allosteric Binding Sites for Other Modulators and Lipids
The GluCla-ivermectin and a1-GlyR-ivermectin structures provide unique information about the underlying molecular mechanisms of PAMs and allosteric agonists acting at the TMD intersubunit interface. Ivermectin is an allosteric agonist of GluCla, and a quasi-irreversible potentiator of the a1-GlyR, also acting at its TMD (Duret et al., 2011; Hibbs and Gouaux, 2011) . Ivermectin contacts the M2 and M3 a-helices from the ''principal'' subunit, and the M1 a-helix from the ''complementary'' subunit ( Figure 6A ). This cavity is accessible from the extra-vestibular lipid environment, whereas the previously described general anesthetic site is accessible from the channel (Figure 6 ). An analysis between the resting-apo and ivermectin-bound open forms of GluCla, as well as the strychnine-closed and ivermectinbound open forms of a1-GlyR, shows that ivermectin is situated between an expansion of the M1 and M3 a-helices in the intersubunit cavity ( Figure 6A ). The cavity created by ivermectin is not seen with comparisons to other structures, such as those of GLIC, 5-HT 3 AR, or b3-GABA A R.
Interestingly, GluCla-apo crystals, grown in the presence of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), were found, after a month long incubation at 4 C, to yield a new conformation of GluCla with a POPC molecule bound at the level of the ivermectin-binding site. The choline moiety of POPC blocks the M2 a-helix from tilting toward the M1 a-helix, whereby the open-pore conformation with ivermectin is not seen and the M3/ M4 a-helices resemble that of the apo structure, yet the constriction of the pore seen in the apo structure is not present (Figures 3  and 6B ). Although POPC blocks the M2 a-helix from tilting away into the open conformation, the push into the vestibule actually produces a more open rotation than that of the apo structure. Surprisingly the selectivity filter at À2 0 is reorganized to a rather exacerbated open-conformation, a phenomenon that is also seen in the a1-GlyR-glycine bound structure. This suggests that POPC may trap a conformation resulting from thermal fluctuation and causes a local distortion of the protein structure (Koshland, 1959) . Arg123 of the orthosteric pocket maintains the open form rotamer, while Lys171 maintains the apo form, adding to the uniqueness of the POPC structure ( Figure 5B) .
Altogether, these data suggest that the TMD displays an overall higher degree of tertiary structural flexibility as compared to the b-sandwich core of the ECD. This distinctive feature may be important in mediating the action of lipids and cholesterol (daCosta et al., 2013) , as well as PAMs and NAMs, notably those developed on the a7-nAChRs, which are thought to bind at an intra-subunit cavity (Gill-Thind et al., 2015) .
Conclusion 50 years after the publication of the MWC theory, the molecular mechanism of signal transduction of pLGICs is emerging thanks to the comparison of X-ray structures in different conformations (Figure 7) . The ECD of homopentameric pLGICs undergo quaternary motions that greatly alter the regulatory orthosteric binding site, located at the subunit interface (Figures 4 and 5) . Although functionally unique between subfamilies, the motions in the ECD seem highly conserved, whereas the TMD seems more flexible and/or variable in conformational changes among species. In the near future, it is likely that new structures will be released, providing an assessment of the pertinence and accuracy of gating models developed for mammalian pLGICs from lower organism pLGICs.
A central hypothesis of the MWC theory is that ligands stabilize the state for which they display the highest affinity. The activation model summarized here suggests how neurotransmitters might stabilize receptor activation at the synapse and allow speculation about the structural basis for such affinity differences at the orthosteric site, and some key allosteric sites. The data reviewed could provide the basis for the design of molecules targeting specific sites involved in pLGIC modulation. To optimize ligand affinity, previous in silico models have relied mainly on fixed conformations of pLGICs in order to investigate the ligand-receptor interaction. The gating models presented here should stimulate investigation of the relative affinity between states that govern ligand efficacy, paving the way for the rational design of positive or negative allosteric modulators as well as orthosteric agonists and competitive antagonists.
